Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

(2014) Aaron M Newman et al.   NATURE MEDICINE

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

(2013) Sarah-Jane Dawson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers

(2013) I. Kinde et al.   Science Translational Medicine

Abstract 5145: Glycolytic gene expression in ER-positive breast cancer tumors: Comparison with metastasis scores

(2012) Cindy Christopherson et al.   CANCER RESEARCH

Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting

(2012) Lisa M. McShane et al.   JOURNAL OF CLINICAL ONCOLOGY

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

(2012) Luis A. Diaz Jr et al.   NATURE

The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy

(2011) C. Suzuki et al.   ANNALS OF ONCOLOGY

Detection and quantification of rare mutations with massively parallel sequencing

(2011) I. Kinde et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents

(2009) J. Tol et al.   ANNALS OF ONCOLOGY

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

(2008) Steven J. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating mutant DNA to assess tumor dynamics

(2008) Frank Diehl et al.   NATURE MEDICINE